{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-118948","form_type":"8-K","ticker":"CERS","cik":"0001020214","company_name":"CERUS CORP","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.396357+00:00","generated_at":"2026-05-30T07:56:18.869720+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cerus Q3 product revenue $46.0M (+16% YoY); raises FY2024 guidance to $177-179M","bullets":["Net loss narrowed to $2.9M ($0.02/sh) from $7.3M; positive non-GAAP adjusted EBITDA of $4.4M.","Product revenue guidance raised to $177-179M from $175-178M; IFC guidance raised to $9-10M.","Signed new 6-year BARDA contract up to $248M for INTERCEPT RBC advancement through PMA licensure.","CE Mark review for INTERCEPT RBCs denied; assessing strategy for resubmission with TÜV-SÜD.","Generated positive operating cash flow for third straight quarter; cash & investments $75.6M at Q3 end."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-118948","json":"https://secwatch.observer/filing/0000950170-24-118948.json","markdown":"https://secwatch.observer/filing/0000950170-24-118948.md","text":"https://secwatch.observer/filing/0000950170-24-118948.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1020214/000095017024118948/0000950170-24-118948-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1020214/000095017024118948/cers-20241030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:56:18.869720+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}